View Article

Abstract

Nasal drug delivery has gained significant attention as a convenient, effective, and promising route for systemic drug administration. This approach is favored because of the nasal cavity’s rich blood supply, large surface area, and its ability to bypass hepatic first-pass metabolism, intestinal metabolism, and degradation in the gastrointestinal tract. The present review aims to present an overview of the naso-pulmonary drug delivery system, including its advantages and disadvantages, mechanisms of drug absorption, anatomical features of the nasal cavity and respiratory tract, factors influencing nasal absorption, various dosage forms, innovative formulations, and recent developments in nasal drug delivery technologies. The intranasal route has emerged as one of the most extensively explored areas in pharmaceutical research for the delivery of polar compounds, hormones, vaccines, proteins, and peptides. Owing to the favorable properties of the nasal mucosa for targeted delivery, various therapeutic agents can be administered intranasally to achieve local, systemic, and central nervous system (CNS) effects. Currently, naso-pulmonary drug delivery systems (NPDS) are being widely studied for direct drug transport to the brain and CNS to achieve rapid therapeutic responses.

Keywords

Nasopulmonary Drug Delivery ,Intranasal drug Delivery ,Pulmonary Drug Delivery, Respiratory Drug delivery

Introduction

The nasal route has been recognized as a promising method for drug administration, offering faster and more efficient absorption. This is because the nasal mucosa is more permeable to various compounds than the gastrointestinal tract, owing to the absence of pancreatic and gastric enzyme activity, the neutral pH of nasal mucus, and minimal dilution compared to gastrointestinal contents. Intranasal therapy has long been a recognized treatment method in the Ayurvedic system of Indian medicine. In recent years, many drugs have demonstrated improved systemic bioavailability when administered nasally compared to oral routes. At present, inhalation therapy is the preferred approach for managing respiratory conditions such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). These localized treatments enable the use of smaller doses while minimizing systemic side effects. Inhalation has long been the most traditional and widely used method for delivering medications to the lungs and airways. Drugs administered through this route serve three primary purposes: prevention, treatment of local or systemic diseases, and therapeutic management. Various inhalation devices—such as nebulizers, metered-dose inhalers, dry powder inhalers, and other aerosol-based technologies—are utilized for effective drug delivery. Intranasal drug delivery is increasingly acknowledged as a practical and dependable alternative to oral and parenteral routes. For many years, nasal administration has been commonly used for symptom relief and for the prevention or treatment of various nasal disorders. In this method, drugs are introduced through the nasal cavity, allowing for both topical and systemic delivery—depending on whether the medication acts locally within the nasal passages or enters systemic circulation to produce broader therapeutic effects.

Anatomy of Nose: -

The anatomy of the nose is essential for understanding nasal drug delivery, as its structure directly affects drug deposition, absorption, and clearance. The nose can be divided into external and internal parts, and each region has specific functions relevant to drug delivery.

1.External Nose

Composed of bone and cartilage. Includes the nasal bridge, dorsum, tip, alae (sides), and nostrils (nares). Acts as the primary entry for air and inhaled drugs.

2. Internal Nose

The internal nasal cavity extends from the nostrils to the nasopharynx and is divided by the nasal septum into two chambers.

  1. Nasal Vestibule

The anterior part of the nasal cavity. Lined with stratified squamous epithelium and contains hair (vibrissae) that filters large particles.

  1. Respiratory Region

Makes up most of the nasal cavity. Lined with ciliated pseudostratified columnar epithelium with goblet cells that produce mucus. Highly vascularized, enabling rapid drug absorption. Contains turbinates/conchae (superior, middle, inferior):

Increase surface area for warming, humidifying, and filtering air. Direct airflow and affect drug deposition.

c. Olfactory Region

Located at the roof of the nasal cavity. Contains olfactory receptor neurons responsible for the sense of smell. Provides a direct pathway to the central nervous system, useful for nose-to-brain drug delivery.

3. Blood Supply

Nasal cavity is richly vascularized by branches of the internal and external carotid arteries, including:

  • Sphenopalatine artery
  • Anterior and posterior ethmoidal arteries
  • Facial artery
  • Dense vascular network facilitates rapid systemic absorption of drugs.

4. Lymphatic Drainage

Lymph vessels drain into the cervical lymph nodes. Plays a role in immune response and vaccine delivery.

5. Nasal Functions Relevant to Drug Delivery

Filtration: Nasal hairs trap large particles.

Humidification and warming: Turbinates condition inhaled air.

Mucociliary clearance: Moves mucus and trapped particles to the pharynx; affects residence time of drugs.

Absorption: Rich vascularization and thin epithelial lining enhance systemic drug uptake.

If you want, I can create a labeled diagram of the nasal anatomy highlighting the regions important for drug delivery. This makes it much easier to visualize for NPDS purposes.

Reference

  1. A J. Hickev. Pharmaceutical Inhalation Aerosol Technology, 2nd edition, Marcel Dekker, NY, 2004 Alagusundaram M., Deepthi N., Ramkanth S., Angala-parameswari S., Mohamed Saleem T.S., Gnanapra-kash K. Thiruvengadarajan V. S, Madhusudhana Chetty C, Dry Powder Inhalers - An Overview,Int. J. Res. Pharm. Sci. 2010, 1;1: 34-42
  2. Armengot, M., Basterra, Macro,.Rev. Larngol.Octol. Rhinol. 1990, 111,219-226 Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov Today 2002; 7,18, 967-975.
  3. Aulton M.E. " Pharmaceutics - The science of dosage form design" Churchill Livingston., 494, 2002 Aurora J. Development of Nasal Delivery Systems: A Review.Drug Deliv Technol 2002; 2,7, 1-8.
  4. Buri P. Hydrogels destines a la muqueuse nasale. Controle physiologique, Pharm. Acta Helv. 1966,41, 88-101.
  5. Chien Y.W., Su K.S.E., Chang S.F., Nasal Systemic Drug Delivery, Ch. 1, MarcelDekker, New York, 1-77, 1989
  6. Johnson NJ, Hanson LR, Frey WH. Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol Pharm, 2010; 7: 884-93.
  7. Svensson S, Olin AC, Hellgren J. Increased net water loss by oral compared to nasal expiration in healthy subjects. Rhinology, 2006; 44: 74-7.
  8. Rudman KL, O’Brien EK, Leopold DA. Radiographic distribution of drops and sprays within the sinonasal cavities. Am J Rhinol Allergy, 2011; 25: 94-7.
  9. 2. Illum. L., Jorgensen. H. Bisgard. Hand Rossing. N, Bioadhesivemicrospheres as a potential nasal drug delivery system. Int. J. of Pharmaceutics, 189-199.
  10. Akwete, A.L., Gupta, P.K., Eds.; Niven, delivery of biotherapeutics by inhalation aerosol. In Inhalation Delivery of Therapeutic Peptides and Proteins; Marcel Dekker, Inc., New York, 1997; 151-2
  11. Patton, J.S. Mechanisms of macromolecule absorption by the lungs: Adv. Drug Delivery Rev, 1996; 3-36.
  12. Rhidian, R., & Greatorex, B., Chest pain in the recovery room, following topical intranasal cocaine solution use. British Medical Journal Case Reports doi: 10.1136/bcr-2015- 20969
  13. Slot, W.B., Merkus, Deventer, (1997). Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12- deficient patients. Gastroenterology. 113, 430-433.
  14. Singh, L., & Khan, A. D., Nasal drug delivery: a promising way for brain targeting. The Pharma Research 13.2, 1-12.
  15. S.G., Illum, L., Thomas, N.W., 1991. Nasal absorption in rats. II. Effect of enhancers on insulin absorption and nasal histology. International Journal Pharmaceutics. 76, 61-70
  16. Ugwoke, M. I., Agu, R. U., Verbeke, N., & Kinget, R. (2005). Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Advanced Drug Delivery Reviews, 57(11), 1640-1665.
  17. Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001). The biopharmaceutical aspects of nasal mucoadhesive drug delivery. Journal of Pharmacy and Pharmacology, 53(1), 3-22.
  18. Zhou, M., Donovan, M.D., 1996. Recovery of the nasal mucosa following laureth-9 induced damage. International Journal of Pharmaceutics.130, 93-102.
  19. Harris, A.S., (1993). Review: Clinical opportunities provided by the nasal administration of peptides. Journal of Drug Targeting 1, 101-116.
  20. Hermann, N., (2015). Effectiveness of live attenuated influenza vaccines and trivalent inactivated influenza vaccines against confirmed influenza in children and adolescents in Saxony-Anhalt, 2012/13. Gesundheitswesen 77(7): 499-501
  21. Knoester, P.D., Jonker, Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. British Journal of Clinical Pharmacology. 53, 501-507.
  22. Kublik, H., & Vidgren, M. T., (1998). Nasal delivery systems and their effect on deposition and absorption. Advanced Drug Delivery Reviews, 29, 157-177.
  23. Mahdi, M. H., Conway, B. R., (2015). Development of mucoadhesive sprayable gellan gum fluid gels. International Journal of Pharmaceutics, 488(1), 12-19.
  24. Merkus, F. W. H. M., Schipper, (1993). Absorption enhancers in nasal drug delivery: efficacy and safety. Journal of Controlled Release, 24(1), 201-208.
  25. Mundlia, J., & Mukesh, K. (2015). Nasal drug delivery: An overview. International Journal of Pharmaceutical Sciences and Research 6, 951-956.

Photo
Chopade Pooja
Corresponding author

Bachelor of Pharmacy, Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad

Photo
Adhav Akanksha
Co-author

Bachelor of Pharmacy, Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad

Photo
Shinde Reshma
Co-author

Bachelor of Pharmacy, Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad

Photo
Patil Shreya
Co-author

Bachelor of Pharmacy, Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad

Photo
Jagtap Puja
Co-author

Bachelor of Pharmacy, Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad

Chopade Pooja*, Adhav Akanksha, Shinde Reshma, Patil Shreya, Jagtap Puja, A Review: Nasopulmonary Drug Delivery System, Int. J. Sci. R. Tech., 2025, 2 (11), 404-409. https://doi.org/10.5281/zenodo.17611705

More related articles
Assessment Of Emotional Intelligence Among Adolesc...
R Suvarnamma, Dr. S. Hemalatha, Dr. M. Bhagyalakshmi, ...
Advances and Current Practices in Assisted Reprodu...
Manjima Sunil, Hamlin Joseph Antony , ...
A Review on Weed Characteristic and Weed Managemen...
Jaypal Kathakiya, Anusha Maitreya, Himanshu Pandya, ...
A Review on Pharmacological Activity and Phytochemical Analysis of Ceiba Specios...
Dr. S. R. Butle, Mansi Lungase, Gopika Nawgaje, Tejasvi Tribhuwan, Shruti Waikar, Mayuresh Rajurkar,...
From Attraction to Attachment: An Integrative Neuroendocrine Model of Female Rom...
Arnab Roy, Mahesh Kumar Yadav, Kajal Kumari , Anchal Kumari, KM Anshika Patel , Divya Kumari , Bhum...
Related Articles
Antiviral Drug Development in The Post-COVID Era: Innovations, Challenges, and F...
Sandesh Shelke, Vedant Shivange, Dr. Avinash Darekar , ...
A Study On "Culturing Paramecium and Analyzing Their Impact on Guppies’ Growth...
V Sai Sruthi , Dr. T. Jagadeeshwara Chari, D. Ramkumar, ...
Credit Card Fraud Detection Based on Feature Selection and Enhanced Support Vect...
Shan Ali Abdula, Hersh Fakhradin Aziz, Pavel Ali Abdula, Salam Aham Ali, Pehraw Salam Abdalqadir, ...
Assessment Of Emotional Intelligence Among Adolescents at Selected College in Ti...
R Suvarnamma, Dr. S. Hemalatha, Dr. M. Bhagyalakshmi, ...